InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
AI Subscribe Login/Register account icon
S&P 500
5,722.26
(
-0.19%
)
US TECH 100
19,494.78
(
0.41%
)
Dow Jones
41,914.75
(
-0.70%
)
Brent Oil
73.19
(
-1.84%
)
Bitcoin
63,201.73
(
-1.66%
)
Post# of 492
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next

ICURhere2

Send PM Follow Ignore
Followers 0
Posts 27
Boards Moderated 0
Alias Born 01/25/2021

ICURhere2

Re: toro123 post# 384

Wednesday, 02/24/2021 11:57:55 PM

Wednesday, February 24, 2021 11:57:55 PM

Post# of 492
It's on the way back. I've had this since it was 30, and have not been disappointed. They have no peers, and a unique design. Canadian gov believes in them.

LexaGene's MiQLab is designed for point-of-care use and for simultaneous screening of numerous respiratory pathogens, including COVID-19 strain identification. The system is open-access, which allows for new tests to be easily loaded onto the system. This is a unique feature that is not found in any other system designed for point-of-care use.

I'm good waiting for this one to get big... fun to watch.
Public Reply Private Reply New Post
Keep Last Read
Replies (1) Keep Last Read Next 10 Report Keyboard Shortcuts
Replies (1) Next 10 Prev Next
Join InvestorsHub

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up